300
Participants
Start Date
March 31, 2006
Primary Completion Date
December 31, 2010
Study Completion Date
March 31, 2011
S-1
S-1 capsule at a dose of 80 mg/m2 b.i.d. for 4 weeks followed by 2 weeks rest.
Nagoya University Hospital, Nagoya
Department of frontier surgery,Draduate school of medicine,Chiba University, Chiba
Kyusyu University Faculty of Medical Sciences, Fukuoka
Kyusyu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka
Fukushima Medical University Hospital, Fukushima
Gunma University Hospital, Maehashi
Hakodate Goryoukaku Hopsital, Hakodate
Hyogo Prefectural Awaji Hospital, Sumoto
Ishikawa Prefectural Central Hospital, Kanazawa
Kanazawa Medical University Hospital, Kanazawa
Iwate Medical University Hospital, Morioka
Department of surgical oncology and digestive surgery kagoshima university graduate school, Kagoshima
Nippon Medical School Second Hospital, Kawasaki
St. Marianna University, School of Medicine, Kawasaki
Kitazato University East Hospital, Sagamihara
Faculty of Medical and Pharmaceutical Sciences Kumamoto University, Kumamoto
Niigata Prefectural Cancer Center, Niigata
Hirakata City Hospital, Hirakata
Osaka Kita Japan Post Hospital, Osaka
Osaka City University Graduate School of Medicine, Osaka
Saiseikai Suita Hospital, Suita
Osaka Medical College Hospital, Takatsuki
Yao Municipal Hospital, Yao
Saga Medical School Faculty of Medicine,Saga University, Saga
Jichi Medical School Hospital, Shimono
Dokkyo University School of Medecine, Shimotsuga
Tochigi Cancer Center, Utsunomiya
Surugadai Nihon University Hospital, Chiyoda-ku
Tobu Chiiki Hospital, Katsushika-ku
Cancer Institute Hospital, Koto-ku
Keio University Hospital, Shinjuku-ku
Nippon Medical School Tama Nagayama Hospital, Tama
Tottori University Faculty of Medicine, Yonago
Kouseiren Takaoka Hospital, Takaoka
Wakayama Prefectural Medical University Hospital, Wakayama
Kanagawa Prefectural Cancer Center, Kanagawa
Kitasato University
OTHER
Japan Clinical Cancer Research Organization
OTHER